Literature DB >> 9395830

Acute posterior multifocal placoid pigment epitheliopathy: a long-term study.

T V Roberts1, P Mitchell.   

Abstract

PURPOSE: To study the long-term visual outcome in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE).
METHODS: Fifteen patients (28 eyes) with APMPPE were reassessed at Westmead Hospital Eye Clinic (Westmead, NSW, Australia) up to 18 years (mean 6.4 years) after their initial presentation to one of the authors (PM) or to their private ophthalmologist. Stereo retinal photographs and visual acuities taken at the initial presentation were compared with those obtained at the most recent follow-up visit.
RESULTS: The last recorded visual acuity was 6/6 or better in 16 eyes (57%), 6/9-6/18 in four eyes (14%), 6/24-6/60 in five eyes (18%) and worse than 6/60 in three eyes (11%). Nine patients (60%) were treated with oral prednisone during the acute episode with little therapeutic effect observed. Six patients (40%) described a prodromal flu-like illness.
CONCLUSION: This study suggests that the long-term visual outcome following an acute episode of APMPPE may not be as favourable as initially portrayed by Gass. It confirms other study findings suggesting that APMPPE may not be a benign self-limiting disease. Older age at onset and initial foveal involvement were associated with a worse visual outcome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395830     DOI: 10.1111/j.1442-9071.1997.tb01515.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  8 in total

1.  [White dot syndromes : Principles, diagnostics, and treatment].

Authors:  Dominika Pohlmann; Sibylle Winterhalter; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

2.  A syndrome resembling acute posterior multifocal placoid pigment epitheliopathy in older adults.

Authors:  Alexander Taich; Mark W Johnson
Journal:  Trans Am Ophthalmol Soc       Date:  2008

3.  Multifocal electroretinographic evaluation of macular function in acute posterior multifocal placoid pigment epitheliopathy.

Authors:  Ranko Aoyagi; Takaaki Hayashi; Tamaki Gekka; Kenichi Kozaki; Hiroshi Tsuneoka
Journal:  Doc Ophthalmol       Date:  2013-03-08       Impact factor: 2.379

4.  Classification Criteria for Acute Posterior Multifocal Placoid Pigment Epitheliopathy.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-09       Impact factor: 5.488

5.  Neurological Manifestations of Acute Posterior Multifocal Placoid Pigment Epitheliopathy.

Authors:  Hussein Algahtani; Ashjan Alkhotani; Bader Shirah
Journal:  J Clin Neurol       Date:  2016-10       Impact factor: 3.077

6.  Long-term multimodal imaging in acute posterior multifocal placoid pigment epitheliopathy and association with coxsackievirus exposure.

Authors:  Alexa L Li; Neal V Palejwala; Jessica G Shantha; Ghazala O'Keefe; Cecilia S Lee; Thomas Albini; Steven Yeh
Journal:  PLoS One       Date:  2020-08-24       Impact factor: 3.752

7.  Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of Cases.

Authors:  Ioannis Papasavvas; Alessandro Mantovani; Carl P Herbort
Journal:  Medicina (Kaunas)       Date:  2022-08-08       Impact factor: 2.948

8.  Untreated Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): a case series.

Authors:  Olivia Xerri; Sawsen Salah; Dominique Monnet; Antoine P Brézin
Journal:  BMC Ophthalmol       Date:  2018-03-20       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.